In a patient weighing 103 kg (BMI 35) on prednisone 80 mg daily, currently receiving 17 units of NPH insulin with a 1‑unit‑per‑5‑g carbohydrate ratio, and with blood glucose readings of 114 mg/dL at 8 am, 143 mg/dL at noon, 248 mg/dL at 2 pm, 393 mg/dL at 5 pm, and 239 mg/dL at 9 pm, how much should the NPH insulin dose be increased?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dose Adjustment for Steroid-Induced Hyperglycemia

Increase the NPH insulin dose by approximately 6-8 units (bringing the total to 23-25 units once daily in the morning), and strongly consider converting to a twice-daily NPH regimen given the severe afternoon/evening hyperglycemia pattern.

Clinical Context Analysis

Your patient demonstrates the classic hyperglycemic pattern of steroid-induced diabetes: acceptable morning fasting glucose (114 mg/dL) but severe afternoon/evening hyperglycemia (393 mg/dL at 5 pm). This pattern directly reflects prednisone's pharmacodynamics—glucocorticoids cause peak hyperglycemia 4-12 hours after morning administration 1.

The current regimen of 17 units NPH is inadequate. At 103 kg body weight on 80 mg prednisone, this patient requires more aggressive insulin dosing.

Recommended Dosing Strategy

Immediate Action: Convert to Twice-Daily NPH

The 2025 ADA Standards of Care specifically recommend considering morning NPH dosing for steroid-induced hyperglycemia 2. Given your patient's blood glucose pattern, a twice-daily NPH regimen is superior to once-daily dosing:

  • Total NPH dose: Start with 80% of a recalculated dose = approximately 24-28 units total daily
  • Distribution: 2/3 in the morning (16-19 units), 1/3 in the evening (8-9 units) 2
  • Rationale: This matches the biphasic hyperglycemic effect of once-daily prednisone

Dosing Calculation Based on Evidence

Research demonstrates optimal insulin-to-steroid ratios for glycemic control 3:

  • For high-dose steroids (>40 mg prednisone): 0.085 U/kg/10-mg PED total insulin
  • For your patient: 103 kg × 0.085 × 8 (80mg/10mg) = 70 units total daily insulin

However, this represents total insulin (basal + prandial + correction). For NPH alone targeting steroid-induced hyperglycemia:

More conservative evidence-based approach 4, 5:

  • High-dose steroids (>40 mg prednisone): 0.3 U/kg NPH = 103 kg × 0.3 = 31 units
  • Split as: 21 units morning, 10 units evening

Alternative calculation from recent research 6:

  • 0.40 units per mg prednisone = 80 × 0.40 = 32 units total NPH

Specific Titration Protocol

Following ADA guidelines 2:

  1. Day 1: Increase to 21 units NPH in morning (0600-0800h), add 10 units NPH in evening (1800-2000h)
  2. Titration: Increase by 2 units every 3 days based on fasting and pre-dinner glucose targets
  3. Target: Fasting glucose 70-130 mg/dL, pre-dinner glucose <180 mg/dL
  4. Hypoglycemia management: If BG <70 mg/dL without clear cause, reduce dose by 10-20% 2

Critical Considerations

Why Twice-Daily NPH is Superior Here

The blood glucose trajectory (114→143→248→393→239 mg/dL) shows:

  • Adequate overnight/morning control (suggesting current basal is working for fasting)
  • Severe afternoon hyperglycemia (NPH from morning dose wearing off)
  • Evening hyperglycemia persisting (no coverage for afternoon steroid effect)

Single morning NPH peaks at 4-8 hours and wanes by afternoon—this explains the 393 mg/dL at 5 pm 7, 8.

Prandial Insulin Consideration

Your patient already uses 1:5 carb ratio with correction insulin. Continue this regimen but recognize that:

  • The correction doses are likely insufficient (hence persistent hyperglycemia)
  • Consider increasing correction factor sensitivity if hypoglycemia doesn't occur
  • The 2025 ADA guidelines suggest adding 4 units rapid-acting insulin at the largest meal if A1C remains above goal 2

Steroid-Specific Guidance

The 2025 ADA explicitly states: "Consider dosing NPH in the morning for steroid-induced hyperglycemia" 2. This acknowledges that:

  • Prednisone 80 mg given in morning causes peak hyperglycemia 4-12 hours later
  • NPH's intermediate action (peak 4-8 hours) matches this pattern when dosed appropriately
  • Evening NPH dose prevents overnight hyperglycemia from residual steroid effect

Safety Monitoring

Research shows NPH for steroid-induced hyperglycemia is safe with appropriate dosing 8, 4:

  • Hypoglycemia rates: 0.1% severe hypoglycemia in clinical trials
  • More aggressive initial dosing (0.5 units/mg prednisone) achieved earlier euglycemia without increased hypoglycemia 8

Common Pitfalls to Avoid

  1. Underdosing: Your current 17 units (0.16 U/kg or 0.21 units/mg prednisone) is below evidence-based targets
  2. Single daily dosing: Inadequate for high-dose steroids with once-daily administration
  3. Relying on correction insulin: This creates a reactive rather than proactive approach
  4. Ignoring the pattern: The 5 pm spike of 393 mg/dL demands scheduled insulin coverage, not just corrections

Monitoring Plan

  • Check pre-meal and bedtime glucose daily
  • Adjust NPH doses every 2-3 days based on patterns
  • If hypoglycemia occurs, reduce corresponding NPH dose by 10-20% 2
  • When prednisone is tapered or discontinued, rapidly reduce NPH as insulin requirements drop precipitously 7, 1

References

Research

Insulin Dosing and Glycemic Outcomes Among Steroid-treated Hospitalized Patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2022

Research

HOSPITAL INSULIN PROTOCOL AIMS FOR GLUCOSE CONTROL IN GLUCOCORTICOID-INDUCED HYPERGLYCEMIA.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

When tapering prednisone from 80 mg to 70 mg in a patient currently taking 17 units of NPH (neutral protamine Hagedorn) insulin and a carbohydrate‑to‑insulin ratio of 1 unit per 5 g carbohydrate, what should the new NPH insulin dose and carbohydrate‑to‑insulin ratio be?
For a patient on prednisone 50 mg daily, NPH insulin 10 units, and an insulin‑to‑carbohydrate ratio of 1 unit per 5 g carbohydrate, if the prednisone dose is reduced to 40 mg, what should the NPH insulin dose and the insulin‑to‑carbohydrate ratio be adjusted to?
Given a patient on prednisone 40 mg daily, receiving NPH insulin 15 units and using a 1‑unit per 10‑gram carbohydrate ratio, with capillary blood glucose readings of 237 mg/dL at 8 am, 215 mg/dL at noon, 255 mg/dL at 4 pm, 270 mg/dL at 9 pm, and 290 mg/dL at 1 am, should I restart the patient’s home insulin glargine (Lantus) dose of 16 units?
In a patient on continuous tube feeding (220 g carbohydrate) and prednisone 20 mg twice daily, receiving NPH insulin 20 units at 8 pm and an insulin drip of 3 U/h until 8 am, then 1.5 U/h for 4 h, then 3 U/h for 8 h, how much should the morning NPH dose be increased?
If a patient on prednisone 60 mg is receiving NPH insulin 12 units with a carbohydrate‑to‑insulin ratio of 1 unit per 5 g, and the prednisone dose is reduced to 50 mg, what should the NPH insulin dose and the carbohydrate‑to‑insulin ratio be adjusted to?
What is the appropriate management for a patient who is scoring +2 on the Richmond Agitation‑Sedation Scale?
What is the best medication for a 54-year-old man with maintenance insomnia and dysthymia?
In a 54-year-old man with maintenance insomnia and dysthymia, how do trazodone and mirtazapine compare in terms of efficacy, dosing, side effects, and indications for use?
What is an appropriate daily dietary plan for a generally healthy 50‑year‑old man?
What are the recommended drug dosages and management approach for adult thyrotoxicosis?
Should phenazopyridine (Phenazoline) be given to a patient with new‑onset atrial fibrillation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.